Trending News

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

BREAKING: District Court Restores Status Quo Ante At NLRB

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences
Posted On Thursday, February 27, 2025
Certara Reports Fourth Quarter 2024 Financial Results
Posted On Wednesday, February 26, 2025
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Posted On Wednesday, February 26, 2025
Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
Posted On Wednesday, February 26, 2025
Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)
Posted On Wednesday, February 26, 2025
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences
Posted On Wednesday, February 26, 2025
Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference
Posted On Wednesday, February 26, 2025
Kura Oncology Reports Fourth Quarter and Full Year 2024 Financial Results
Posted On Wednesday, February 26, 2025
Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress
Posted On Wednesday, February 26, 2025
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
Posted On Wednesday, February 26, 2025
scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences
Posted On Wednesday, February 26, 2025
AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance
Posted On Wednesday, February 26, 2025
Shuttle Pharma Provides Corporate Update and Reports 2024 Results
Posted On Wednesday, February 26, 2025
Derm-Biome’s DB-007-5 is highly effective at treating atopic dermatitis and reducing itch in preclinical study, outperforming the current leading topical AD drug
Posted On Wednesday, February 26, 2025
Renovaro Announces $15 million in Equity Committed
Posted On Wednesday, February 26, 2025
ONE Retreats’ Transformative Psilocybin Wellness Initiative Addresses Mental Health Conditions for Veterans
Posted On Wednesday, February 26, 2025
Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives
Posted On Wednesday, February 26, 2025
AIM ImmunoTech Appoints David Chemerow to Board of Directors as an Independent Director
Posted On Wednesday, February 26, 2025
PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA Oncology
Posted On Wednesday, February 26, 2025
CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
Posted On Wednesday, February 26, 2025
Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
Posted On Wednesday, February 26, 2025
Bio Usawa Appoints Dr. Patrick Lukulay as Chief Operating Officer
Posted On Wednesday, February 26, 2025
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
Posted On Wednesday, February 26, 2025
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH Cirrhosis
Posted On Wednesday, February 26, 2025
Benitec Biopharma to Participate in Upcoming Conferences in March
Posted On Wednesday, February 26, 2025

Print